欢迎您加入月均活跃用户100万+的科研社区!如您有任何系统建议,请点此洽谈。
;如有合作推广需求,请近期推荐: | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 | 新 已发表SCI?是时候来Springer出书了! |
![]() |
基本信息 | 登录收藏 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | European Journal of Pharmacology EUR J PHARMACOL (此期刊被最新的JCR期刊SCIE收录) LetPub评分 7.2
77人评分
我要评分
声誉 7.7 影响力 6.2 速度 8.8 | |||||||||||||||||||||
期刊ISSN | 0014-2999 | ![]() 蝌蝌APP,让您与同行交流更轻松
![]() | ||||||||||||||||||||
E-ISSN | 1879-0712 | |||||||||||||||||||||
2024-2025最新影响因子 (数据来源于搜索引擎) | 4.7 点击查看影响因子趋势图 | |||||||||||||||||||||
实时影响因子 | 截止2025年5月19日:4.674 | |||||||||||||||||||||
2024-2025自引率 | 2.10%点击查看自引率趋势图 | |||||||||||||||||||||
五年影响因子 | 4.7 | |||||||||||||||||||||
JCI期刊引文指标 | 1.37 | |||||||||||||||||||||
h-index | 167 | |||||||||||||||||||||
CiteScore ( 2025年最新版) |
| |||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||
期刊官方网站 | https://www.journals.elsevier.com/european-journal-of-pharmacology | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
期刊投稿网址 | https://www.editorialmanager.com/EUJPH | |||||||||||||||||||||
期刊语言要求 | Language Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足European Journal of Pharmacology的语言要求,还能让European Journal of Pharmacology编辑和审稿人得到更好的审稿体验,让稿件最大限度地被European Journal of Pharmacology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评(1篇) 论文致谢(6篇) 。 提交文稿 | |||||||||||||||||||||
是否OA开放访问 | No | |||||||||||||||||||||
通讯方式 | ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE | |||||||||||||||||||||
出版商 | Elsevier | |||||||||||||||||||||
涉及的研究方向 | 医学-药学 | |||||||||||||||||||||
出版国家或地区 | NETHERLANDS | |||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||
出版周期 | Weekly | |||||||||||||||||||||
出版年份 | 1967 | |||||||||||||||||||||
年文章数 | 706点击查看年文章数趋势图 | |||||||||||||||||||||
Gold OA文章占比 | 17.12% | |||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 97.73% | |||||||||||||||||||||
WOS期刊JCR分区 ( 2024-2025年最新版) | WOS分区等级:1区
| |||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||
中国科学院期刊分区 ( 2025年3月最新升级版) | 点击查看中国科学院期刊分区趋势图
| |||||||||||||||||||||
中国科学院期刊分区 ( 2023年12月升级版) |
| |||||||||||||||||||||
中国科学院期刊分区 ( 2022年12月旧的升级版) |
| |||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0014-2999%5BISSN%5D | |||||||||||||||||||||
平均审稿速度 | 网友分享经验: 平均1.4个月 来源Elsevier官网: 平均7.9周 | |||||||||||||||||||||
平均录用比例 | 网友分享经验: 约53.57% | |||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在European Journal of Pharmacology顺利发表。
快看看作者怎么说吧:服务好评(1篇) 论文致谢(6篇) 。 提交文稿 | |||||||||||||||||||||
期刊常用信息链接 |
|
|
|
|
中国学者近期发表的论文 | |
1. | Tissue-specific mechanism of estrogen in osteoporosis and vascular calcification Author: Wu, Wei; Qiao, Aike; Du, Tianming Journal: EUROPEAN JOURNAL OF PHARMACOLOGY. 2025; Vol. 1002, Issue , pp. -. DOI: 10.1016/j.ejphar.2025.177783 PubMed DOI |
2. | Teneligliptin, a DPP4 inhibitor protects dopaminergic neurons in PD models via inhibiting of oxidative stress and ferroptosis Author: Huang, Linting; Pi, Jiakai; Gu, Liqin; Liao, Zirou; Wang, Wenya Journal: EUROPEAN JOURNAL OF PHARMACOLOGY. 2025; Vol. 1002, Issue , pp. -. DOI: 10.1016/j.ejphar.2025.177782 PubMed DOI |
3. | Super-enhancers and Mef2c: Novel regulators of cardiac hypertrophy via the Hey2/Notch/p38 signaling pathway Author: Wang, Ruixuan; Ba, Lina; Wang, Rui; Zhao, Zhichao; Wu, Nan; Liu, Renling; Feng, Xiang; Sun, Hongli; Qi, Hanping Journal: EUROPEAN JOURNAL OF PHARMACOLOGY. 2025; Vol. 1002, Issue , pp. -. DOI: 10.1016/j.ejphar.2025.177771 PubMed DOI |
4. | Resveratrol ameliorates cognitive impairment with improvement of gut microbiota, inflammation, neurogenesis, and synaptic proteins in a mouse model of Gulf War Illness Author: Li, Yanna; Wang, Xinyi; Yuan, Linying; Liu, Zhihui; Li, Rui; Cai, Yulong; Liu, Xinfeng Journal: EUROPEAN JOURNAL OF PHARMACOLOGY. 2025; Vol. 1002, Issue , pp. -. DOI: 10.1016/j.ejphar.2025.177768 PubMed DOI |
5. | Escitalopram can reverse co-occurring depression and overactive bladder induced by corticosterone in rats Author: Liu, Gongyue; Zhou, Zhonghan; Liu, Xin; Sun, Haoyu; He, Zitian; Deng, Han; Shang, Dongsheng; Ji, Junjie; Liao, Limin Journal: EUROPEAN JOURNAL OF PHARMACOLOGY. 2025; Vol. 1002, Issue , pp. -. DOI: 10.1016/j.ejphar.2025.177809 PubMed DOI |
6. | Toward precision dosing of linezolid in critical ill patients: efficiency and risk of thrombocytopenia analysis by population PKPD modeling and simulations Author: Qin, Yan; Jiao, Zheng; Ye, Yan-Rong; Wang, Zi; Zou, Ye; Shen, Yun; Lv, Qian-Zhou Journal: EUROPEAN JOURNAL OF PHARMACOLOGY. 2025; Vol. 1002, Issue , pp. -. DOI: 10.1016/j.ejphar.2025.177777 PubMed DOI |
7. | Advancements in RNA-targeted therapies for renal cell carcinoma Author: Zhang, Hanzhong; Lin, Anqi; Cai, Chen; Liu, Ying; Fang, Yu; Luo, Peng; Jiang, Aimin; Wang, Linhui Journal: EUROPEAN JOURNAL OF PHARMACOLOGY. 2025; Vol. 1002, Issue , pp. -. DOI: 10.1016/j.ejphar.2025.177788 PubMed DOI |
8. | The liver-gut axis perspective: Exploring the pathogenesis of fatty liver Author: Yang, Zonghui; Zhang, Jinbao; Liu, Xiaona; Chen, Honggang; Duan, Haijing; Wang, Qian; Zhao, Wenlong; Jin, Ling Journal: EUROPEAN JOURNAL OF PHARMACOLOGY. 2025; Vol. 1002, Issue , pp. -. DOI: 10.1016/j.ejphar.2025.177822 PubMed DOI |
9. | lncRNA CASC9 stabilizes MUC1 by binding to U2AF2 to inhibit cellular ferroptosis and alleviate LPS-induced cell injury Author: Chen, Keke; Chen, Chengjie; Chen, Sihu; Zheng, Xiang; Pan, Guoquan; Liang, Yafeng Journal: EUROPEAN JOURNAL OF PHARMACOLOGY. 2025; Vol. 1002, Issue , pp. -. DOI: 10.1016/j.ejphar.2025.177818 PubMed DOI |
10. | Glycyrrhizic acid mitigates hepatocyte steatosis and inflammation through ACE2 stabilization via dual modulation of AMPK activation and MDM2 inhibition Author: Zhou, Longyue; Yi, Yun; Lin, Bingqi; Qiu, Zhenwen; Wang, Chunxia; Li, Yuhao Journal: EUROPEAN JOURNAL OF PHARMACOLOGY. 2025; Vol. 1002, Issue , pp. -. DOI: 10.1016/j.ejphar.2025.177817 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2025 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室